Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other financing activities: 2019-2023

Historic Other financing activities for Eton Pharmaceuticals (ETON) over the last 3 years, with Dec 2023 value amounting to -$1,000.

  • Eton Pharmaceuticals' Other financing activities was N/A to -$1,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $180,000 for FY2023, which is N/A change from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Other financing activities of -$1,000 as of Q4 2023, which was down 100.55% from $181,000 recorded in Q1 2023.
  • Eton Pharmaceuticals' Other financing activities' 5-year high stood at $1.0 million during Q3 2021, with a 5-year trough of -$1,000 in Q4 2023.
  • Over the past 2 years, Eton Pharmaceuticals' median Other financing activities value was $754,500 (recorded in 2021), while the average stood at $593,500.
  • Data for Eton Pharmaceuticals' Other financing activities shows a peak YoY surged of 84.38% (in 2021) over the last 5 years.
  • Over the past 4 years, Eton Pharmaceuticals' Other financing activities (Quarterly) stood at $501,000 in 2019, then soared by 54.29% to $773,000 in 2020, then grew by 11.64% to $863,000 in 2021, then reached -$1,000 in 2023.
  • Its Other financing activities was -$1,000 in Q4 2023, compared to $181,000 in Q1 2023 and $863,000 in Q4 2021.